The Scientist

» filovirus and culture

Most Recent

image: Debating the Value of Anonymity

Debating the Value of Anonymity

By | October 5, 2015

PubPeer responds to criticism that anonymous post-publication peer review threatens the scientific process.

1 Comment

image: Ready, Willing, and Able

Ready, Willing, and Able

By | October 1, 2015

Researchers with disabilities are making their fields more accessible.

0 Comments

image: Study: Men Get Bigger Start-Up Packages

Study: Men Get Bigger Start-Up Packages

By | September 17, 2015

A new analysis reveals yet another gender gap in science.

0 Comments

image: Opinion: Pay-to-Play Publishing

Opinion: Pay-to-Play Publishing

By | September 3, 2015

Online scientific journals are sacrificing the quality of research articles to make a buck.

3 Comments

image: Capsule Reviews

Capsule Reviews

By | September 1, 2015

Brain Storms, Orphan, Maize for the Gods, and Paranoid.

0 Comments

image: Speaking of Science

Speaking of Science

By | September 1, 2015

September 2015's selection of notable quotes

1 Comment

image: Study: Short Headlines Get More Citations

Study: Short Headlines Get More Citations

By | August 27, 2015

Scientific journals that publish papers with snappier titles accrue more citations per paper, according to a report.

0 Comments

image: Opinion: Making Progress by Slowing Down

Opinion: Making Progress by Slowing Down

By | August 24, 2015

Academic research could be strengthened by thinking more and doing less.

5 Comments

image: Book Excerpt from <em>Life on the Edge</em>

Book Excerpt from Life on the Edge

By | August 1, 2015

In Chapter 4, “The quantum beat,” authors Johnjoe McFadden and Jim Al-Khalili rethink Newton’s apple from a quantum-biological perspective.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | August 1, 2015

Gods of the Morning, Hedonic Eating, A Beautiful Question, and Genomic Messages

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham